Evidence map›Paper›PMID 34341170›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2021

Expansion of Unique Hepatitis C Virus-Specific Public CD8

Sabrina Mazouz, Maude Boisvert, Mohamed S Abdel-Hakeem, Omar Khedr, Julie Bruneau, Naglaa H Shoukry

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Sabrina MazouzCentre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.ORCID 0000-0002-0090-3299
Maude BoisvertCentre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.ORCID 0000-0001-9304-7796
Mohamed S Abdel-HakeemCentre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.ORCID 0000-0003-0226-3464
Omar KhedrCentre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Julie BruneauCentre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada.
Naglaa H ShoukryCentre de Recherche du Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada; naglaa.shoukry@umontreal.ca.ORCID 0000-0002-8817-8238
Centre Hospitalier de l’Université de Montréal · CA

Funding

Protective immunity to HCV and rational vaccine designU19AI159819 · NIAID · EMORY UNIVERSITY · PI Arash Grakoui · 2021 to 2026
$16.6M
Dynamics of antigen specific B and Tfh responses during acute and chronic HCVR01AI136533 · NIAID · EMORY UNIVERSITY · PI GRAKOUI, ARASH · 2018 to 2022
$3.8M
T Cell Immunity and HCV Infection OutcomeU01AI131313 · NIAID · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI WALKER, CHRISTOPHER M. · 2016 to 2020
$1.3M
CIHR NHC142832CIHR PJT-173467NIAID NIH HHS R01 AI136533NIAID NIH HHS U01 AI131313NIAID NIH HHS U19 AI159819
6 · The paper itself

Abstract

Hepatitis C virus (HCV) infection resolves spontaneously in ∼25% of acutely infected humans where viral clearance is mediated primarily by virus-specific CD8

Indexed as

CD8-Positive T-LymphocytesClone CellsCross-Sectional StudiesEpitopes, T-LymphocyteHepacivirusHepatitis CHLA-A2 AntigenHumansImmunodominant EpitopesReceptors, Antigen, T-CellReceptors, Antigen, T-Cell, alpha-betaReinfectionEpitopes, T-LymphocyteHLA-A2 AntigenImmunodominant EpitopesReceptors, Antigen, T-CellReceptors, Antigen, T-Cell, alpha-beta

Identifiers

PMID34341170
PMCPMC8434894
OpenAlexW3189589686

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.